Aarey Drugs & Pharmaceuticals Ltd

NSE: AAREYDRUGS BSE: 524412

₹69.28

(3.48%)

Sun, 29 Mar 2026, 10:03 pm

MTF 5xInvest in Aarey Drugs & Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap1.95B

PE Ratio57.39

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Aarey Drugs & Pharmaceuticals Financials

Income Statement Balance Sheet Cashflow

Particulars	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total revenue	275.31M	465.03M	646.64M	1.30B	1.72B	2.00B	2.13B	2.46B	3.96B	3.49B	3.54B	2.98B	3.48B	4.92B	4.18B	3.95B	4.72B
Gross profit	9.07M	15.00M	16.09M	19.04M	25.65M	22.61M	17.22M	19.49M	117.44M	109.56M	121.14M	61.79M	89.17M	169.54M	115.07M	109.58M	78.06M
Operating expenses (excl. COGS)	0	-6.55M	-6.40M	-8.80M	-11.03M	-15.55M	-14.18M	-15.54M	-27.14M	-37.05M	-52.16M	-38.26M	-50.48M	-51.80M	-20.51M	-31.37M	-12.70M
Selling/general/admin expenses, total	—	-5.72M	-5.94M	-8.13M	-11.03M	-15.55M	-14.18M	-15.54M	-27.14M	-26.90M	-42.17M	-38.10M	-50.34M	-69.79M	-42.83M	-75.67M	-67.31M
Research & development	—	-180.00K	0	—	0	0	0	0	0	—	—	—	—	—	—	—	—
Selling/general/admin expenses, other	—	-5.54M	-5.94M	-8.13M	-11.03M	-15.55M	-14.18M	-15.54M	-27.14M	-26.90M	-42.17M	-38.10M	-50.34M	-69.79M	-42.83M	-75.67M	-67.31M
Other operating expenses, total	0	-836.08K	-460.65K	-664.05K	0	0	0	0	0	-10.15M	-9.98M	-165.40K	-137.41K	17.99M	22.32M	44.30M	54.61M
Operating income	9.07M	8.44M	9.69M	10.24M	14.63M	7.06M	3.04M	3.95M	90.30M	72.52M	68.99M	23.53M	38.69M	117.74M	94.56M	78.21M	65.36M
Non-operating income, total	49.48K	1.07M	264.31K	-6.13M	-5.60M	6.35M	11.06M	14.18M	-10.52M	9.40M	20.87M	48.90M	44.32M	-17.37M	-34.47M	-24.78M	-4.35M
Interest expense, net of interest capitalized	-22.02K	-16.41K	-982.39K	-7.05M	-7.48M	-9.45M	-14.85M	-17.18M	-43.29M	-19.20M	-22.30M	-17.85M	-24.43M	-20.37M	-28.67M	-43.75M	-46.64M
Interest capitalized	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Non-operating income, excl. interest expenses	65.11K	1.44M	1.25M	921.52K	1.88M	15.80M	25.91M	31.36M	33.25M	28.60M	43.17M	66.75M	68.76M	3.00M	-5.30M	18.97M	42.30M
Non-operating interest income	—	5.09K	46.01K	394.03K	700.69K	14.09M	24.28M	29.28M	29.34M	25.83M	0	26.15M	24.25M	666.00K	127.00K	349.00K	789.00K
Miscellaneous non-operating expense	65.11K	1.43M	1.20M	527.49K	1.18M	1.71M	1.64M	2.09M	3.90M	2.76M	43.17M	40.60M	44.51M	2.33M	-5.42M	18.62M	41.51M
Unusual income/expense	6.39K	-352.02K	—	—	—	—	—	—	-473.13K	—	—	0	0	0	-500.00K	0	0
Pretax income	9.12M	9.51M	9.96M	4.11M	9.03M	13.41M	14.10M	18.13M	79.78M	81.92M	89.86M	72.42M	83.01M	100.37M	60.10M	53.43M	61.02M
Taxes	-1.38M	-1.41M	-2.05M	-1.27M	-2.44M	-2.90M	-3.22M	-5.24M	-25.05M	-20.14M	-24.44M	-14.49M	-17.87M	-34.82M	-22.39M	-6.59M	-20.78M
Non-controlling/minority interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
After tax other income/expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net income before discontinued operations	7.74M	8.11M	7.91M	2.84M	6.58M	10.51M	10.88M	12.89M	54.74M	61.78M	65.42M	57.94M	65.14M	65.55M	37.71M	46.84M	40.24M
Net income	7.74M	8.11M	7.91M	2.84M	6.58M	10.51M	10.88M	12.89M	54.74M	61.78M	65.42M	57.94M	65.14M	65.55M	37.71M	46.84M	40.24M
Dilution adjustment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred dividends	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Diluted net income available to common stockholders	7.74M	8.11M	7.91M	2.84M	6.58M	10.51M	10.88M	12.89M	54.74M	61.78M	65.42M	57.94M	65.14M	65.55M	37.71M	46.84M	40.24M
Basic earnings per share (Basic EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted earnings per share (Diluted EPS)	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	13.67M	13.12M	14.73M	16.14M	20.72M	13.60M	13.89M	10.45M	96.70M	79.63M	79.07M	32.47M	47.89M	137.63M	110.30M	95.19M	84.81M
EBIT	9.07M	8.44M	9.69M	10.24M	14.63M	7.06M	3.04M	3.95M	90.30M	72.52M	68.99M	23.53M	38.69M	117.74M	94.56M	78.21M	65.36M
Total operating expenses	-266.24M	-456.59M	-636.95M	-1.29B	-1.71B	-1.99B	-2.13B	-2.46B	-3.87B	-3.42B	-3.48B	-2.95B	-3.44B	-4.80B	-4.08B	-3.87B	-4.66B
Prepaid expenses	402.77K	313.40K	130.85M	120.73M	—	—	34.35M	1.74M	274.93K	21.90M	—	19.95M	22.48M	54.72M	24.63M	27.47M	222.65M
Deferred income, current	—	—	—	—	—	14.74M	2.64M	6.00M	42.16M	40.18M	0	—	—	8.86M	33.77M	50.66M	39.33M
Capital and operating lease obligations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating lease liabilities	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	—	—	0	—	0	0	—	—	15.34M	12.98M	14.92M	14.40M	15.63M	14.55M	14.15M	7.49M	9.19M
Deferred income, non-current	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Minority interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in accrued expenses	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Common dividends paid	0	0	—	0	0	0	0	0	0	0	-2.34M	0	0	0	0	0	0
Preferred dividends paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800